Introduction
Innate and adaptive immune cells modulate the accumulation and metabolism of specific substrates to meet functional demands during a response. Macrophages and granulocytes, for example, increase expression of glucose transporters and glycolytic enzymes through HIF-1α to generate energy required for phagocytosis and cytokine secretion in inflamed tissue (1) . Both B and T lymphocytes switch from oxidative phosphorylation to glycolysis after antigen stimulation in order to meet biosynthetic demands during clonal expansion (2) (3) (4) . Recently, it has been shown that differentiation of effector T cells to memory T cells is accompanied by a switch in energy production from glycolysis to beta oxidation of fatty acids (5) . These findings indicate that measurements of specific metabolic processes in immune cells may inform about the function of the immune system during disease. The effect of therapies designed to alter immune function might also be assessed through analysis of immune cell metabolism.
PET is a noninvasive imaging modality that is capable of detecting subnanomolar concentrations of a positron-labeled probe distributed throughout the body (6) . PET probes for cellular metabolic pathways enable quantitative in vivo measurements of cellular biochemistry. [ 18 F]-2-fluorodeoxyglucose ([ 18 F]-FDG) is a positron-labeled glucose analog that accumulates in tissues with high rates of glycolytic metabolism and is commonly used in the clinic to measure tumor cell glucose metabolism and its response to therapy (reviewed in ref. 7) .
The critical role of glycolysis in the function of many immune cell types has resulted in [ 18 F]-FDG PET being used to measure immune responses in vivo. In animal models, [ 18 F]-FDG PET detects tissue-specific immune activation during experimental autoimmune encephalitis (8) , colitis (9) , rheumatoid arthritis (10) , and graft-versus-host disease (GVHD) (11) . [ 18 F]-FDG PET has clinical application to visualize inflammation in atherosclerotic plaques (12) , in synovial tissue during rheumatoid arthritis (13) , and in the gut during GVHD (11) . [ 18 F]-FDG PET also has utility in the diagnosis and management of numerous infectious disorders resulting in chronic osteomyelitis, fever of unknown origin, vascular graft infection, and AIDS (reviewed in ref. 14) .
Glucose is an example of a substrate whose metabolism is dynamically regulated in innate and adaptive immune cells. Immune cells also require a variety of other metabolites such as essential amino acids (15) , membrane (16) and nucleotide precursors, and vitamins (17) . These metabolic requirements are based on a combination of cell-intrinsic metabolic programs and microenvironmental factors during an immune response. Concurrent measurements of differentially regulated metabolic pathways with PET may enable more thorough evaluation of immune cell function in vivo.
We recently developed [ 18 F]-2-fluoro-d-(arabinofuranosyl)cytosine ([ 18 F]-FAC), a fluorinated deoxycytidine analog that is taken up by cells and trapped in a phosphorylation-dependant manner by deoxycytidine kinase (DCK) (18) . DCK is the rate-limiting step in the deoxycytidine salvage pathway, and its expression is enriched in hematolymphoid tissues (19) . Animals genetically deficient for DCK are viable but have drastically reduced numbers of mature T cells and B cells (20) Intramuscular inoculation with the Moloney murine sarcoma virus/murine leukemia virus complex (MSV/MuLV) results in the rapid growth and regression of a nonmetastatic rhabdomyosarcoma (22) . The antitumor response peaks 12-15 days after infection and depends upon CD4 + and CD8 + T cells that recognize specific viral epitopes in collaboration with infiltrating innate cells (23, 24) . MSV/MuLV infection also stimulates B cells to produce antibodies against viral proteins (25) . Hematogenous shedding of viral antigens results in immune activation in distal parts of the body, such as the spleen. This model allowed interrogation of specific cellular components of the immune system in disparate anatomical sites using in vivo PET imaging, in situ staining, cell sorting, and in vitro and in vivo cell labeling with metabolic probes.
We Figure 1A ). Naive mice that were not challenged with MSV/MuLV were used to establish the baseline accumulation patterns for each probe.
Naive mice typically show high [ 18 F]-FDG accumulation in the heart and brain, which rely heavily on glucose metabolism. Brain signal can vary between mice during imaging based on the time each animal spends under anesthesia (26) . As was shown in the initial characterization (27) MSV/MuLV challenge results in the activation and mobilization of multiple immune cell types. The metabolic PET signals observed during infection may reflect changes in the density of various immune cells in tissues. In order to assess the distribution of different immune cell types, we removed the spleen, DLN, and tumor 14 days after MSV/MuLV infection, then cryosectioned and stained these tissues with antibodies against cell surface antigens present on innate and adaptive immune cell subsets (Figure 2A ). The spleen, lymph nodes, and muscle from unchallenged mice were harvested and stained for comparison with the immune-activated state. We counted the number of positively stained cells in 10 random ×40 fields of view from at least 3 different tissue sections. The average counts were normalized to the surface area of the field of view and presented as an average cell density of the number of cells per square millimeter (cells/mm 2 ) ( Figure 2B ).
We observed that CD4 + T cells increased approximately 3-fold in density in the spleen and approximately 9-fold in the DLN 14 days after MSV/MuLV infection. There was also infiltration of 
Cell-intrinsic [ 3 H]-2-deoxy-d-glucose accumulation is highest in innate immune cells, while [ 3 H]-FAC accumulates predominantly in CD8 + T cells.
Radiologic and microscopic analyses showed that tissues accumulating deoxycytidine salvage probes in sorted cell population was measured in parallel using an ex vivo probe accumulation assay. A total of 10 5 of each cell type were placed in wells of a microtiter plate and pulse labeled with Figure 1A) ; thus, we used single-cell suspensions of naive lymph nodes to establish a baseline for probe accumulation. Radiation counts were normalized to the specific activity of each probe and presented as femtomoles per 10 5 cells. Data from 3 independent sorting experiments were combined ( Figure 3, C and D) . We found that [ 3 H]-2DG preferentially accumulated in innate cell types that stained CD11b hi ( Figure 3C ). CD11b is a pan-myeloid marker present on both macrophages and granulocytes. Further analysis of the myeloid cell populations showed that the tumor and the spleen contained a mixture of macrophages and granulocytes based on positive staining with antibodies against F4/80 and Gr-1, respectively (data not shown). Compared with the spleen, the tumor samples contained fewer granulocytes and were enriched for macrophages, as evidenced by diminished Gr-1 expression and increased F4/80 expression (data not shown). Tumor-infiltrating CD11b hi myeloid cells exhibited approximately 4-fold more
Figure 2
Inoculation with MSV/MuLV leads to increased density of diverse immune cell types in lymphoid organs and transformed muscle tissue. (A) Tumor, DLN, and spleens were harvested from MSV/MuLV-infected mice 14 days after inoculation, at the peak of the antitumor response, sectioned, and stained with antibodies for CD4, CD8, B220, and CD11b (original magnification: ×20; insets, ×40). CD8 + T cells from unchallenged mice lacked CD25 expression and had the CD44 lo CD62L hi naive phenotype ( Figure 4A ). On day 14 of the anti-MSV/MuLV response, the CD8 + T cell population in the DLN contained a mixture of CD44 lo CD62L hi naive cells and CD44 hi CD62L lo effector-memory cells. A subset of CD8 + T cells in the DLN were CD25 hi . The CD8 + T cell population in the tumor was composed almost entirely of CD44 hi CD62L lo effector-memory cells, and few cells in this population were CD25 hi .
Cytotoxic T cell populations from the DLN and tumor differed in their activation phenotype. We then assessed how CD8 + T cell activation phenotype was related to deoxycytidine salvage activity. [ 3 H]-FAC accumulation data from Figure 3D were extracted to compare CD8 + T cells in the tumor and DLN and naive lymphocytes ( Figure 4B ). CD8 + T cells in the tumor accumulated less [ 3 H]-FAC per cell than those in the DLN (greater than 2-fold decrease). However, CD8 + T cells in the tumor still accumulated approximately 5-fold more probe than the naive lymphocyte control. We observed that, on average, proportionately fewer of these tumor-infiltrating CD8 + T cells were in S-G 2 -M of the cell cycle when compared with DLN CD8 + T cells ( Figure 4C ). This was consistent with our observation that tumor-infiltrating CD8 + T cells expressed predominantly an effector-memory phenotype and had mostly lost expression of CD25, a high-affinity isoform of the IL-2 receptor that facilitates the early T cell proliferative response to mitogenic signals. Thus, intracellular FAC accumulation may reflect shifts in requirements by T cells for deoxycytidine salvage activity as they differentiate from naive cells through early effector stages to effector-memory states.
[
H]-2DG accumulation and Glut1 expression in T cell populations activated in vivo is lower than that in T cells stimulated with anti-CDand IL-2. Ex vivo analysis demonstrated that different immune cell
types preferentially accumulated probes for distinct metabolic pathways in a cell-autonomous manner. In this assay, CD8 + and The glucose transporter Slc2a1 (Glut1) is a major regulator of glucose uptake in T cells upon activation (31, 32) . We analyzed the relative levels of Glut1 expression among in vitro stimulated T cells, CD4 + and CD8 + T cells from the DLN of infected mice, and naive lymphocytes ( Figure 5B ). Glut1 was expressed at high levels in in vitro stimulated T cells and was not detected in naive lymphocytes. Glut1 expression was detected in CD8 + T cells from the DLN, but the level of expression was much lower than that in the population activated in vitro. Glut1 expression was not detected in CD4 + T cells from the DLN. These results suggest that a much smaller fraction of CD8 + T cells are glycolytically active during the anti-MSV/MuLV response compared with in vitro mitogenic stimulation and that this metabolic activity cannot be appreciated with ex vivo [ 3 H]-2DG pulse labeling.
F]-FDG and [ F]-FAC differentially accumulate in innate and adaptive immune cell types in vivo.
To assess the sequestration of to assess the presence of adaptive immune cells at this site. In stark contrast, [ 18 F]-FAC accumulation in the tumor was low in immune-competent mice, and this signal was not changed in the immune-deficient condition, even in the absence of functional adaptive immune cells at this site. From our results in Figure  2 , A and B, and Figure 4 , we suspect that lower T cell density in the tumor coupled with lower deoxycytidine salvage activity in tumor-infiltrating effector-memory cells results in the low levels of [ 18 F]-FAC signal observed in this tissue.
Discussion
We investigated the capacity of PET imaging probes for two distinct metabolic pathways to label different cell types during an immune response. (33) (34) (35) .
Glycolysis is also critical to T cells during activation-induced clonal expansion. Aerobic glycolysis resulting from mitogen stimulation in oxygen-rich conditions leads to high levels of intracellular glucose that drive membrane and protein biosynthesis and enable proliferation (2, 31) Under hypoxic conditions, glucose is shunted away from biosynthetic pathways toward energy production, lowering proliferative capacity (36 Figure 2) . Thus, although murine immune cells are active for thymidine salvage, they appear unable to retain FLT. The specific membrane transporters that mediate uptake of FLT have yet to be defined. It is possible that there is a species difference in FLT transport between human and mouse cells that hinders probe accumulation in mouse tissues. Serum thymidine does not limit (20) . Tumors, however, can often overcome a lack of DCK and continue to proliferate. Tumors treated with nucleoside analog prodrugs that are activated by DCK (for example, gemcitabine and cytarabine) may eventually lose tumor DCK expression, resulting in resistance to this class of drugs and disease progression (42, 43 
Methods
Animals and MSV/MuLV inoculation. C57BL/6 and CB17 SCID/SCID animals were bred and maintained according to the guidelines of the UCLA Department of Laboratory Animal Medicine (DLAM). All animal studies were carried out using protocols approved by DLAM. MSV/MuLV stocks were produced as reported previously (45) . Six- to 14-week-old C57BL/6 animals were inoculated in the shoulder muscle with 100 μl of a 1:800 dilution of the viral stock solution in PBS. Six- to 12-week-old CB17 SCID/SCID animals were given intramuscular inoculations of 100 μl of the MSV-MuLV stock solution diluted 1:1,000 in PBS.
MicroPET/CT imaging. Mice were warmed under gas anesthesia (2% isoflurane) and injected intravenously with 200 μCi of either [ 18 F]-FDG or [ 18 F]-FAC, followed by 1 hour uptake. Following uptake, mice were positioned in an imaging chamber for sequential imaging with the Siemens Preclinical Solutions microPET Focus 220 and MicroCAT II CT systems (Siemens). MicroPET data were acquired for 10 minutes and reconstructed with a statistical maximum a posteriori (MAP) probability algorithm into multiple frames (46) . MicroPET and CT images were coregistered as previously described (47) . Quantification of PET signal in specific anatomical regions was performed by drawing 3D ROIs using AMIDE software (http://amide. sourceforge.net/) (48) . The mean intensity of the ROI, based on the percent injected dose per gram, was normalized to a background ROI drawn around uninfected muscle in the same animal (21) . Data are presented as fold change over background. Images are presented here using a falsecolor scale that is proportional to tissue concentration of positron-labeled probe: red represents the highest concentrations, with yellow, green, and blue corresponding to sequentially lower values.
Whole-body autoradiography. Tumor-bearing mice were injected intravenously with 1 mCi of either [ 18 F]-FDG or [ 18 F]-FAC and killed 1 hour later. Mice were embedded in 3% carboxymethylcellulose and frozen in liquid nitrogen. Sections (100 μm) were cut using a Leica CM3600 XP cryomacrotome, exposed overnight on BAS-TR2025 imaging screens (FujiFilm Life Science) at -20°C, and visualized using a BAS-5000 phosphor imager (FujiFilm Life Science).
Cryosectioning and immunohistochemistry. Tumors, spleens, and DLNs were harvested, embedded, and stained as described previously (45) . Frozen sections were stained with the following biotinylated antibodies: rat anti-CD11b (clone: M1/70), rat anti-B220 (clone: RA3-6B2), rat anti-CD4 (clone: GK 1.5), and rat anti-CD8 (clone: 53.6.7). Peroxidase-conjugated Streptavidin-HRP (Dako) was used as a secondary reagent for the biotinylated antibodies. To assess the distribution of each immune cell type in the different tissues, positively stained cells from 10 random ×40 fields of view on at least 3 different sections were counted. The average number of positive cells from these counts was divided by the area of the field of view (0.047 mm 2 ) to give an approximate measurement of cells/mm 2 .
Dissociation of tissues from MSV/MuLV-infected mice. Tumors, DLNs, and spleens from MSV/MuLV-infected C57BL/6 animals were removed 14 days after inoculation. The tissues from 3 animals were pooled for each experiment. Tumors were minced and incubated for 40 minutes at 37°C in HEPES buffer containing DNAse, 1 mg/ml collagenase and hyaluronidase. Tumor pieces were then pressed through a 70-μm cell strainer and centrifuged through a Nycodenz gradient (Accurate Chemical and Scientific Corp.) for 20 minutes at 754 g. Cells were collected from the interface for antibody staining and cell sorting. Spleens were cut in small pieces and incubated for 40 minutes at 37°C in HEPES buffer containing DNAse and 1 mg/ml collagenase. Spleen pieces were pressed through a 70-μm cell strainer and washed, and red blood cells were lysed in 0.8% ammonium Statistics. Data in bar graphs are presented as mean ± SEM. Graph production and analysis were performed with GraphPad Prism software, version 5. Multiple group comparisons were done using the Student's t test. Correlations were measured by linear regression analysis. P values less than 0.05 were considered significant.
